إعلان
إعلان

PROF

PROF logo

Profound Medical Corp. Common Stock

8.17
USD
برعاية
+0.44
+5.67%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

8.19

+0.02
+0.21%

تقارير أرباح PROF

النسبة الإيجابية المفاجئة

PROF تفوق 15 من 39 آخر التقديرات.

38%

التقرير التالي

بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$7.54M
/
-$0.28
التغير الضمني من Q3 25 (Revenue/ EPS)
+42.59%
/
+7.69%
التغير الضمني من Q4 24 (Revenue/ EPS)
+80.54%
/
+40.00%

Profound Medical Corp. Common Stock earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, PROF reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.36 USD, resulting in a 29.48% surprise. Revenue reached 5.29 مليون, compared to an expected 5.04 مليون, with a 4.85% difference. The market reacted with a +7.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.28 USD, with revenue projected to reach 7.54 مليون USD, implying an زيادة of 7.69% EPS, and زيادة of 42.59% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, Profound Medical Corp. Common Stock reported EPS of -$0.26, beating estimates by 29.48%, and revenue of $5.29M, 4.85% above expectations.
The stock price moved up 7.87%, changed from $6.35 before the earnings release to $6.85 the day after.
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
Based on 5 المحللين, Profound Medical Corp. Common Stock is expected to report EPS of -$0.28 and revenue of $7.54M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان